Bibliografía
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30.
2. Hundal R, Schaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99-109
3. American Cancer Society. Cancer Facts & Figures 2017.
4. Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94:342-60.
5. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485-89.
6. Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC Study Group. World J Surg. 2011;35:1887-97.
7. Pitt SC, Jin LX, Hall BL, et al. Incidental gallbladder cancer at cholecystectomy: when should the surgeon be suspicious? Ann Surg. 2014;260:128-33.
8. Choi KS, Choi SB, Park P, et al. Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21:1315-23.
9. Vinuela E, Vega E, Yamashita S, et al. Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: A report from high- and low-incidence countries. Ann Surg Oncol. 2017;24:2334-43.
10. Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer stating manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-4.
11. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591-602.
12. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211-17.
13. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167-76.
14. Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767-71.
15. Ramirez CP, Suárez MA, Santoyo J, et al. Actualización del diagnostic y el tratamiento del cancer de vesicular biliar. Cir Esp. 2002;71:102-11.
16. Wang YF, Feng FL, Zhao XH, et al. World J Gastroenterol. 2014;20(14):4085-92.
17. Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681-90.
18. Löhe F, Meimarakis G, Schauer C, et al. The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma. Eur J Med Res. 2009; 14(8):345-51.
19. Lee SE, Jang JY, LIM CS, et al. World J Gastroenterol 2011; 17(2): 174-80.
20. Watson H, Dasari B, Wyatt J, et al. HBP (Oxford). 2017; 19(2):104-107.
21. Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22(8):2779-86.
22. Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cáncer: an international multicenter study. Ann Surg. 2015;261(4):733-9.
23. Lee W, Jeong CY, Jang JY, et al. Surgery. 2017;162(3):515-524.
24. Liu GJ, Li XH, Chen YX, et al. World J Gastroenterol. 2013;19(31):5150-8.
25. Sternby Eliard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer – a systematic literature review. Scand J Gastroenterol. 2017;52(5):505-514.
26. Jung W, Jang JY, Kang MJ, et al. Effects of surgical methods and tumor location on survival and recurrence patterns after Curative resection in patients with T2 gallblader cancer. Gut Liver. 2016;10(1):140-6.
27. Gani F, Buettner S, Margonis GA, et al. Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. J Surg Oncol. 2016;114(2):176-80.
28. Kasumova GG, Tabatabaie O, Najarian RM, et al. Surgical Management of gallbladder cancer: Simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg. 2017;226(4):625-31.
29. Kim Y, Amini N, Wilson A, et al. Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: A multi-institutional analysis. Ann Surg Oncol. 2016;23(9):2998-3008.
30. Wang J, Narang AK, Sugar EA, et al. Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: A multi - institutional experience. Ann Surg Oncol. 2015;22(suppl 3):S1100-6.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30.
2. Hundal R, Schaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99-109
3. American Cancer Society. Cancer Facts & Figures 2017.
4. Wernberg JA, Lucarelli DD. Gallbladder cancer. Surg Clin North Am. 2014;94:342-60.
5. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485-89.
6. Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC Study Group. World J Surg. 2011;35:1887-97.
7. Pitt SC, Jin LX, Hall BL, et al. Incidental gallbladder cancer at cholecystectomy: when should the surgeon be suspicious? Ann Surg. 2014;260:128-33.
8. Choi KS, Choi SB, Park P, et al. Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21:1315-23.
9. Vinuela E, Vega E, Yamashita S, et al. Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: A report from high- and low-incidence countries. Ann Surg Oncol. 2017;24:2334-43.
10. Edge SB, Byrd DR, Compton CC, et al, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010.
11. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591-602.
12. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211-17.
13. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167-76.
14. Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg. 2006;243:767-71.
15. Ramirez CP, Suárez MA, Santoyo J, et al. Actualización del diagnostic y el tratamiento del cancer de vesicular biliar. Cir Esp. 2002;71:102-11.
16. Wang YF, Feng FL, Zhao XH, et al. World J Gastroenterol. 2014;20(14):4085-92.
17. Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681-90.
18. Löhe F, Meimarakis G, Schauer C, et al. The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma. Eur J Med Res. 2009; 14(8):345-51.
19. Lee SE, Jang JY, LIM CS, et al. World J Gastroenterol 2011; 17(2): 174-80.
20. Watson H, Dasari B, Wyatt J, et al. HBP (Oxford). 2017; 19(2):104-107.
21. Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22(8):2779-86.
22. Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cáncer: an international multicenter study. Ann Surg. 2015;261(4):733-9.
23. Lee W, Jeong CY, Jang JY, et al. Surgery. 2017;162(3):515-524.
24. Liu GJ, Li XH, Chen YX, et al. World J Gastroenterol. 2013;19(31):5150-8.
25. Sternby Eliard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer – a systematic literature review. Scand J Gastroenterol. 2017;52(5):505-514.
26. Jung W, Jang JY, Kang MJ, et al. Effects of surgical methods and tumor location on survival and recurrence patterns after Curative resection in patients with T2 gallblader cancer. Gut Liver. 2016;10(1):140-6.
27. Gani F, Buettner S, Margonis GA, et al. Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. J Surg Oncol. 2016;114(2):176-80.
28. Kasumova GG, Tabatabaie O, Najarian RM, et al. Surgical Management of gallbladder cancer: Simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg. 2017;226(4):625-31.
29. Kim Y, Amini N, Wilson A, et al. Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: A multi-institutional analysis. Ann Surg Oncol. 2016;23(9):2998-3008.
30. Wang J, Narang AK, Sugar EA, et al. Evaluation of adjuvant radiation therapy for resected gallbladder carcinoma: A multi - institutional experience. Ann Surg Oncol. 2015;22(suppl 3):S1100-6.